{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:52:22Z","timestamp":1790009542573,"version":"4.0.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study aimed to investigate the efficacy and safety of intravenous colistin in pediatric patients with nosocomial Gram-negative bacteria infections and to determine factors associated with treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study recruited patients &lt;18 years of age receiving intravenous colistin between January 2014 and December 2018. Clinical data and treatment outcomes were reviewed, and factors associated with treatment outcomes were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>This study included 178 patients with a median age of 3.4 years (range, 0.1\u201317.8). The mean \u00b1 SD dose of colistin prescribed to patients without renal impairment was 5.1\u2009\u00b1\u20090.6\u2009mg\/kg\/day. The clinical response rate was 70.8% in patients receiving colistin for specific treatment. Infection-related mortality and crude mortality were 17.5% and 19.7%, respectively. The nephrotoxicity rate was 29.8%; approximately 70% of the episodes occurred between the 3rd and 7th day of treatment. The presence of at least 2 organ dysfunctions [adjusted hazard ratio (aHR): 7.17; 95% CI: 1.64\u201331.40], septic shock (aHR: 2.69; 95% CI: 1.36\u20135.32) and receiving chemotherapy\/immunosuppressants (aHR: 2.68; 95% CI: 1.36\u20135.25) were observed to be associated with clinical failure. The factors observed to be associated with nephrotoxicity included hypoalbuminemia (aHR: 2.93; 95% CI: 1.26\u20136.78), receiving amphotericin B (aHR: 2.29; 95% CI: 1.16\u20134.52), vancomycin (aHR: 3.36; 95% CI: 1.50\u20137.56) and vasopressors (aHR: 2.57; 95% CI: 1.27\u20135.21).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Colistin is generally effective in the treatment of nosocomial Gram-negative bacteria infections in pediatric patients. Close monitoring of renal function should be considered, especially in high-risk patients. Optimal dosage regimens for pediatric populations to promote more favorable clinical outcomes and minimize nephrotoxicity require further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004450","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T12:02:11Z","timestamp":1719316931000},"page":"1054-1060","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Treatment Outcomes and Associated Factors of Intravenous Colistin for Nosocomial Infections in Pediatric Patients: A Retrospective Study in a University Hospital in Thailand"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5137-0612","authenticated-orcid":false,"given":"Sunisa","family":"Khamlek","sequence":"first","affiliation":[{"name":"From the PhD\u2019s Degree Program in Pharmacy, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand"},{"name":"Division of Clinical Pharmacy, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3555-4682","authenticated-orcid":false,"given":"Aroonrut","family":"Lucksiri","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Faculty of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-4636","authenticated-orcid":false,"given":"Kanokkarn","family":"Sunkonkit","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Pediatrics, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6882-5250","authenticated-orcid":false,"given":"Peninnah","family":"Oberdorfer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7960-6395","authenticated-orcid":false,"given":"Pattarapan","family":"Sukwuttichai","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Training Center, Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/jac\/dkz165","article-title":"Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis.","volume":"74","author":"Karageorgos","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jiac.2017.12.017","article-title":"The evaluation of safety and efficacy of colistin use in pediatric intensive care unit: results from two reference hospitals and review of literature.","volume":"24","author":"Sahbudak Bal","year":"2018","journal-title":"J Infect Chemother"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"e01390","DOI":"10.1128\/JCM.01390-18","article-title":"Antimicrobial susceptibility testing for polymyxins: challenges, issues, and recommendations.","volume":"57","author":"Ezadi","year":"2019","journal-title":"J Clin Microbiol"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijid.2021.06.052","article-title":"Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study.","volume":"109","author":"Wacharachaisurapol","year":"2021","journal-title":"Int J Infect Dis"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/cid\/ciz067","article-title":"Population pharmacokinetics of intravenous colistin in pediatric patients: implications for selection of dosage regimens.","volume":"69","author":"Ooi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R6-20250614","first-page":"555","article-title":"Appropriate use of colistin in neonates, infants and children: interim guidance.","volume":"38","author":"Chibabhai","year":"2023","journal-title":"S Afr J Infect Dis"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)13908-6","article-title":"Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study.","volume":"362","author":"Leteurtre","year":"2003","journal-title":"Lancet (London, England)"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1097\/INF.0000000000000117","article-title":"The use of colistin in critically ill children in a pediatric intensive care unit.","volume":"33","author":"Karbuz","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijantimicag.2012.04.010","article-title":"Old agent, new experience: colistin use in the paediatric intensive care unit\u2014a multicentre study.","volume":"40","author":"Paksu","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.ki.5002231","article-title":"Modified RIFLE criteria in critically ill children with acute kidney injury.","volume":"71","author":"Akcan-Arikan","year":"2007","journal-title":"Kidney Int"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2009.11.016","article-title":"Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.","volume":"35","author":"Cheng","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-0711-12-32","article-title":"Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital.","volume":"12","author":"Karli","year":"2013","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40272-015-0133-5","article-title":"Treatment of ventilator-associated pneumonia using intravenous colistin alone or in combination with inhaled colistin in critically ill children.","volume":"17","author":"Polat","year":"2015","journal-title":"Paediatr Drugs"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.10-2371","article-title":"Antibiotic dosing in multiple organ dysfunction syndrome.","volume":"139","author":"Ulldemolins","year":"2011","journal-title":"Chest"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/jpids\/piz085","article-title":"Treatment of carbapenem-resistant Enterobacteriaceae infections in children.","volume":"9","author":"Chiotos","year":"2020","journal-title":"J. Pediatric Infect. Dis. Soc"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"e02183-19","DOI":"10.1128\/AAC.02183-19","article-title":"Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.","volume":"64","author":"D","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijantimicag.2016.07.018","article-title":"Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic\/pharmacodynamic model.","volume":"48","author":"Liu","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1128\/AAC.01064-12","article-title":"The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic\/pharmacodynamic model.","volume":"56","author":"Deris","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3947\/ic.2021.0007","article-title":"Colistin plus sulbactam or fosfomycin against carbapenem-resistant acinetobacter baumannii: improved efficacy or decreased risk of nephrotoxicity?","volume":"53","author":"Saelim","year":"2021","journal-title":"Infect Chemother"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"e00002","DOI":"10.1128\/AAC.00002-21","article-title":"Population pharmacokinetics and outcomes of critically ill pediatric patients treated with intravenous colistin at higher than recommended doses.","volume":"65","author":"Antachopoulos","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"105940","DOI":"10.1016\/j.ijantimicag.2020.105940","article-title":"Greater optimisation of pharmacokinetic\/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients.","volume":"55","author":"Wacharachaisurapol","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/INF.0000000000001263","article-title":"Pharmacokinetics of colistin following a single dose of intravenous colistimethate sodium in critically ill neonates.","volume":"35","author":"Nakwan","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/jrpp.JRPP_19_68","article-title":"A randomized clinical trial evaluating the efficacy of colistin loading dose in critically ill children.","volume":"8","author":"Fatehi","year":"2019","journal-title":"J Res Pharm Pract"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/jac\/dkaa064","article-title":"Efficacy and safety of colistin loading dose: a meta-analysis.","volume":"75","author":"Bellos","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkz325","article-title":"Mechanisms of antimicrobial-induced nephrotoxicity in children.","volume":"75","author":"Downes","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","article-title":"A review on colistin nephrotoxicity.","volume":"71","author":"Ordooei Javan","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/j.ajkd.2016.03.421","article-title":"Colistin use in patients with reduced kidney function.","volume":"68","author":"Fiaccadori","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"11968","DOI":"10.1038\/s41598-018-30361-5","article-title":"Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment.","volume":"8","author":"Giacobbe","year":"2018","journal-title":"Sci Rep"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness.","volume":"85","author":"Nicholson","year":"2000","journal-title":"Br J Anaesth"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jinf.2010.11.013","article-title":"Risk factors for colistin-associated nephrotoxicity.","volume":"62","author":"Rattanaumpawan","year":"2011","journal-title":"J Infect"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system.","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T19:05:36Z","timestamp":1749927936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004450","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]}}}